Ron Finklestien
Vertex Unit ViaCyte Opts Out of CRISPR Diabetes Program
Vertex Pharmaceuticals’ Subsidiary ViaCyte Takes Exit Cue from CRISPR’s Diabetes Program
undefined On Monday, CRISPR Therapeutics (NASDAQ:CRSP) made known that Vertex Pharmaceuticals (VRTX) cohort ViaCyte has decided to bow out of their collaborative venture focused ...
Assessing Dave & Buster’s (PLAY) Investment — Wall Street’s Encouraging Stance
Assessing Dave & Buster’s (PLAY) Investment — Wall Street’s Encouraging Stance
Brokers are a stock investor’s North Star. But, can the views of these Wall Street pros actually guide your investment moves? Before we delve ...
Why Kirby Corporation (KEX) Is a Compelling Investment Option
Why Kirby Corporation (KEX) Is a Compelling Investment Option
Investors, listen up. Outstanding Performance and Future Potential Kirby Corporation (KEX) has been on a winning streak, and there’s every indication that this is just ...
Dow Surges as Commercial Metals Posts Strong Q1 Results
Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results
U.S. stocks capitalized on a surge in momentum Monday, with the Dow Jones index accelerating over 100 points during trading. The Dow soared 0.35% ...
Bristol-Myers looking for smaller deals after 2023 shopping spree: report
Bristol-Myers Embarks on Smaller Deals Strategy After 2023 Spree The Shift in Bristol-Myers Strategy Bristol Myers Squibb (NYSE:BMY) is set to unveil 16 new ...
Wall Street Analysts’ Perspective on Super Micro’s Future Stock Performance
Wall Street Analysts’ Perspective on Super Micro’s Future Stock Performance
Before diving into the reliability of brokerage recommendations, let’s take a look at what Wall Street analysts have to say about Super Micro Computer ...
UMH Properties Sees Escalating Occupancy and Rental Revenue Amidst Robust Demand
UMH Properties: A Recap of 2023 UMH Properties recently revealed its operational results for the year concluded in 2023, highlighting an upsurge in the ...
Ambrx Biopharma – A Rising Star Amidst Crude Oil’s Tumble
Market Overview The trading day saw mixed fortunes for U.S. stocks. The Nasdaq Composite displayed resilience, securing over a 1% gain on Monday. The ...
The Surge of RxSight and Other Stocks Shaking Up the Market
RxSight, Inc.RXST soared during Monday’s session after the company released preliminary FY23 and FY24 revenue guidance that topped estimates. Additionally, Needham upped its price ...
Verizon’s Stock Rally Comes to a Halt Amid Positive Projections
Verizon’s Stock Rally Comes to a Halt Amid Positive Projections
photobyphm/iStock Editorial via Getty Images After an impressive six-day rally that saw a 7.75% surge, Verizon Communications (NYSE:VZ) shares were poised to experience their ...
